Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Edesa Biotech, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −3 vs. Q4 2021
- Shares held
- 1.85M
- +1.49M (+413.0%) vs. Q4 2021
- Total value
- $5.51M
- +$3.47M (+170.9%) vs. Q4 2021
- New holders
- 1
- 7 more added
- Sold out
- 4
- 3 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $30.0M |
| Q1 2026 | 28 | $13.8M |
| Q4 2025 | 22 | $4.34M |
| Q3 2025 | 23 | $7.10M |
| Q2 2025 | 20 | $4.28M |
| Q1 2025 | 20 | $6.89M |
| Q4 2024 | 17 | $350.1K |
| Q3 2024 | 18 | $718.2K |
| Q2 2024 | 17 | $645.1K |
| Q1 2024 | 17 | $450.9K |
| Q4 2023 | 19 | $507.1K |
| Q3 2023 | 20 | $1.26M |
| Q2 2023 | 22 | $1.63M |
| Q1 2023 | 26 | $2.05M |
| Q4 2022 | 22 | $3.53M |
| Q3 2022 | 21 | $494.2K |
| Q2 2022 | 24 | $2.26M |
| Q1 2022 | 23 | $5.51M |
| Q4 2021 | 26 | $2.03M |
| Q3 2021 | 23 | $2.85M |
| Q2 2021 | 18 | $1.37M |
| Q1 2021 | 16 | $773.7K |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Edesa Biotech, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,456,591 | $4.33M | 0.12% | +1,456,591 | New |
| Vanguard Group Inc | 110,713 | $329.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 82,800 | $246.0K | 0.00% | +49,700+150.2% | Added |
| Geode Capital Management, LLC | 80,269 | $238.0K | 0.00% | +3,020+3.9% | Added |
| Dimensional Fund Advisors LP | 52,670 | $156.0K | 0.00% | +2,800+5.6% | Added |
| State Street Corp | 22,875 | $68.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 15,349 | $46.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 11,106 | $33.0K | 0.00% | −1,511−12.0% | Reduced |
| National Bank of Canada | 10,000 | $30.0K | 0.00% | +9,382+1,518.1% | Added |
| UBS Group AG | 4,028 | $12.0K | 0.00% | +1,208+42.8% | Added |
| Tower Research Capital LLC (TRC) | 2,981 | $9.00K | 0.00% | +2,658+822.9% | Added |
| Royal Bank of Canada | 1,431 | $4.00K | 0.00% | −500−25.9% | Reduced |
| Morgan Stanley | 1,191 | $4.00K | 0.00% | −274−18.7% | Reduced |
| TD Waterhouse Canada Inc. | 1,000 | $2.94K | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 700 | $2.00K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 518 | $2.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 135 | $401 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 104 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 53 | $0 | 0.00% | +1+1.9% | Added |
| Creative Financial Designs Inc | 23 | $0 | 0.00% | 00.0% | Unchanged |
| Credit Agricole S A | 9 | $0 | 0.00% | 00.0% | Unchanged |
| AllSquare Wealth Management LLC | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Fortitude Advisory Group L.L.C. | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −15,082−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,922−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Aquire Wealth Advisors, LLC | 0 | $0 | 0.00% | −43−100.0% | Sold out |